|
发表于 22-6-2014 21:29:59|来自:北京
|
显示全部楼层
这是HSA网站摘的,除了这个还有别的吗?
What is HSA's Role in Cosmetic Products Regulation?
As they are considered to be generally of lower risk than other health products, cosmetic products are currently not subjected to HSA's approval before they are placed on the market. They are also not assessed or approved by HSA for their effectiveness before being sold. Companies who manufacture, import and sell cosmetic products are directly responsible for the safety of their products.
HSA plays its role by setting the guidelines for cosmetic products according to the ASEAN Cosmetic Directive (ACD). The ACD is part of an ASEAN-wide initiative that aims to harmonise standards and requirements for cosmetic products across ASEAN in line with international guidelines.
As part of these safety measures, HSA requires all cosmetic firms to:
•
notify HSA of the products they intend to sell before making them available for sale. This practice is similar to that found in the regulatory systems of countries such as the European Union countries, Thailand and Malaysia.
•
ensure that the products sold are manufactured, prepared, packed and stored under conditions which meet international standards.
•
ensure that their products do not contain any prohibited substances which cause health risks, and that only permitted colourants, preservatives and UV filters are used.
•
label their products clearly. The label must reflect key information such as the product's name, ingredients, country of manufacture and expiry date (if the product has a durability of less than 30 months). Precautionary health warnings must also be included.
•
keep a Product Information File (PIF) on the each cosmetic item they place on the market. This record contains important information such as the product's ingredients as well as data on the product's safety and side effects. The PIF must be presented when audits on the products are conducted by the HSA. This information is also useful in facilitating the recall of the product should health issues arise.
Other checks that we have in our system include:
•
Making it compulsory for cosmetic companies to report all serious adverse events associated with the use of any product to HSA.
•
Conducting routine sampling of cosmetic products after they have been placed on the market, and directing companies to stop selling a product or withdrawing it from the market if it is suspected to pose a health risk.
•
Taking action against persons and companies who violate the legislation on cosmetic products.
|
|